LY550410
LY550410 is a small-molecule ATP-competitive inhibitor against type I TGF-β receptor kinase, which contains heteroaryl rings for potent binding to the kinase-domain active site. LY550410 modulates TGF-β signalling, thereby regulates gene expression and ultimately cell growth. LY550410 is promising for research of cancers[1].
Product Specifications
CAS Number
737791-20-7
UNSPSC
12352005
Target
TGF-β Receptor
Type
Reference compound
Related Pathways
TGF-beta/Smad
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ly550410.html
Smiles
C12=C(C3=C4N(CCC4)N=C3C5=CC=CC=N5)C=CN=C1C=CC=C2
Molecular Formula
C20H16N4
Molecular Weight
312.37
References & Citations
[1]Yingling JM, et al. Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov. 2004 Dec;3 (12) :1011-22.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC943102-500 1x 500 µL
Uroplakin 1B (Urothelial Differentiation Marker) (UPK1B/3102), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2592-100 1x 100 µL
Aldo-keto Reductase Family 1 Member B1 (Adrenal Marker) (CPTC-AKR1B1-2), 0.2mg/mL
Sign In for Pricing
View Details 